Search

Your search keyword '"Ettl A"' showing total 3,748 results

Search Constraints

Start Over You searched for: Author "Ettl A" Remove constraint Author: "Ettl A"
3,748 results on '"Ettl A"'

Search Results

Catalog

Books, media, physical & digital resources

4. PresAIse, A Prescriptive AI Solution for Enterprises

8. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

10. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

11. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

12. Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases

13. Revisions of Evidence-Based Governance: The Case of the Austrian Quality Management System SQA

14. Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.

21. Einleitung

23. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

32. Constrained Prescriptive Trees via Column Generation

35. The immunomodulatory ballet of tumour‐derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD‐L1 pathway in cancer

36. 'Utility of Smartphone-based Three-dimensional Surface Imaging for Digital Facial Anthropometry'

37. Subcellular localization of PD‐L1 and cell‐cycle‐dependent expression of nuclear PD‐L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy

40. Schluss

41. Benchmarking medical laboratory performance on a global scale

42. Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study

43. Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions

44. Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study

45. Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast CancerTalazoparib in Germline BRCA1/2-Mutated Breast Cancer

46. Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study

47. Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study

48. Quantum technology 2.0 -- topics and contributing countries from 1980 to 2018

49. Incidence and Survival of Out-of-Hospital Cardiac Arrest in Public Housing Areas in 3 European Capitals